C-CAMP accelerator shortlists four innovations to deal with Covid-19 spread

A special COVID-19 focussed accelerator set up jointly Centre for Cellular and Molecular Platforms (C-CAMP), United Nations Health Innovation Exchange (UNHIE) and Social Alpha has shortlisted four innovations from over 150 submissions that would focus on building solutions to deal with the pandemic.

Submitted innovations are being reviewed for market readiness, scientific validity, feasibility and impact. There is no specific last date to submit the applications and they are being assessed daily in batches, a statement from C-Camp said.

“Few key players from industry are in constant touch with C-CAMP to support COVID-19 Innovations. CIDA is a step in that direction to help with immediate deployment of solutions wherever we can,” Dr Taslimarif Saiyed, C-CAMP CEO and Director

CIDA is an attempt to align near deployment-ready innovations with unmet needs and help them overcome last-mile gaps wherever and howsoever possible. Through CIDA, innovators will be able to leverage the extensive ecosystem of scientists, regulators, investors and industry in closing last-mile gaps in commercialising their technologies, the statement said.

The accelerator has asked ideas and innovations in categories such as screening, diagnostics, therapeutics, vaccines, containment strategies and public health. It includes scalable plug and play isolation units, treatment tents, protective gear and sterilization innovations for care providers, diagnostic kits and Point of Care tests and volunteerism and service innovations among others.


READ  Internet searches for serious health conditions on the rise

Leave a Reply